Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-28 4:38 pm Sale |
2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA |
BIOGEN IDEC INC BIIB |
0 0.000% |
-8,936,791 (Position Closed) |
Filing History |
| 2023-09-28 4:30 pm Sale |
2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA |
CPMG Inc | 0 0.000% |
-5,020,431 (Position Closed) |
Filing History |
| 2023-09-26 4:32 pm Sale |
2023-09-26 | 13D | Reata Pharmaceuticals, Inc. RETA |
ROSE WILLIAM | 0 0.000% |
-3,182,950 (Position Closed) |
Filing History |
| 2023-09-19 4:31 pm Sale |
2023-09-15 | 13D | Reata Pharmaceuticals, Inc. RETA |
ROSE WILLIAM | 3,182,950 8.900% |
-58,000 (-1.79%) |
Filing History |
| 2023-08-24 4:40 pm Unchanged |
2023-08-23 | 13D | Reata Pharmaceuticals, Inc. RETA |
ROSE WILLIAM | 3,240,950 9.100% |
0 (Unchanged) |
Filing History |
| 2023-08-07 5:21 pm Purchase |
2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA |
BIOGEN IDEC INC BIIB |
8,936,791 23.400% |
8,936,791 (New Position) |
Filing History |
| 2023-08-01 5:17 pm Sale |
2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA |
CPMG Inc | 5,020,431 14.300% |
-9,625 (-0.19%) |
Filing History |
| 2023-07-31 4:56 pm Purchase |
2023-07-28 | 13D | Reata Pharmaceuticals, Inc. RETA |
ROSE WILLIAM | 3,240,950 9.200% |
25,250 (+0.79%) |
Filing History |
| 2023-06-26 4:46 pm Purchase |
2023-06-16 | 13G | Reata Pharmaceuticals, Inc. RETA |
ADAGE CAPITAL PARTNERS GP LLC | 1,730,841 5.240% |
1,730,841 (New Position) |
Filing History |
| 2023-05-15 4:22 pm Sale |
2023-05-12 | 13G | Reata Pharmaceuticals, Inc. RETA |
First Light Asset Management, LLC | 1,319,487 4.000% |
-865,359 (-39.61%) |
Filing History |
| 2023-03-07 11:25 am Purchase |
2023-03-06 | 13G | Reata Pharmaceuticals, Inc. RETA |
PERCEPTIVE ADVISORS LLC | 2,083,799 6.500% |
2,083,799 (New Position) |
Filing History |
| 2023-02-14 4:34 pm Purchase |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
First Light Asset Management, LLC | 2,184,846 6.890% |
2,184,846 (New Position) |
Filing History |
| 2023-02-14 4:12 pm Sale |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
Point72 Asset Management, L.P. | 10,673 0.100% |
-1,653,394 (-99.36%) |
Filing History |
| 2023-02-09 5:47 pm Sale |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
EcoR1 Capital LLC | 0 0.000% |
-1,975,611 (Position Closed) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Reata Pharmaceuticals, Inc. RETA |
The Vanguard Group | 2,705,656 8.530% |
147,983 (+5.79%) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
BLACKROCK INC BLK |
2,501,693 7.900% |
387,643 (+18.34%) |
Filing History |
| 2022-09-22 4:40 pm Purchase |
2022-09-21 | 13G | Reata Pharmaceuticals, Inc. RETA |
Point72 Asset Management, L.P. | 1,664,067 5.300% |
1,664,067 (New Position) |
Filing History |
| 2022-09-09 10:26 am Sale |
2022-08-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
WELLINGTON MANAGEMENT CO LLP | 1,508,638 4.780% |
-2,744,339 (-64.53%) |
Filing History |
| 2022-04-11 4:26 pm Purchase |
2022-03-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
EcoR1 Capital LLC | 1,975,611 6.300% |
1,975,611 (New Position) |
Filing History |
| 2022-03-10 11:32 am Sale |
2022-03-10 | 13G | Reata Pharmaceuticals, Inc. RETA |
Invesco Ltd. IVZ |
372,165 1.200% |
-1,908,244 (-83.68%) |
Filing History |